DrugCite
Search

ZITHROMAC SR

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Zithromac Sr Adverse Events Reported to the FDA Over Time

How are Zithromac Sr adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zithromac Sr, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zithromac Sr is flagged as the suspect drug causing the adverse event.

Most Common Zithromac Sr Adverse Events Reported to the FDA

What are the most common Zithromac Sr adverse events reported to the FDA?

Diarrhoea
29 (6.95%)
Abdominal Pain
13 (3.12%)
Loss Of Consciousness
13 (3.12%)
Rhabdomyolysis
12 (2.88%)
Nausea
9 (2.16%)
Pneumonia
9 (2.16%)
Vomiting
9 (2.16%)
Altered State Of Consciousness
8 (1.92%)
Chest Discomfort
8 (1.92%)
Oedema
8 (1.92%)
Hypoaesthesia
7 (1.68%)
Show More Show More
Hypothermia
7 (1.68%)
Myalgia
7 (1.68%)
Shock
7 (1.68%)
Haematuria
6 (1.44%)
Hepatic Function Abnormal
6 (1.44%)
Malaise
6 (1.44%)
Pyrexia
6 (1.44%)
Arthralgia
5 (1.2%)
Chills
5 (1.2%)
Feeling Abnormal
5 (1.2%)
Platelet Count Increased
5 (1.2%)
Renal Failure Acute
5 (1.2%)
Alanine Aminotransferase Increased
4 (.96%)
Anaphylactic Shock
4 (.96%)
Aspartate Aminotransferase Increase...
4 (.96%)
Asthenia
4 (.96%)
Blast Cell Crisis
4 (.96%)
Cardiac Failure
4 (.96%)
Dyspnoea
4 (.96%)
Eosinophilic Pneumonia
4 (.96%)
Hyperglycaemia
4 (.96%)
Interstitial Lung Disease
4 (.96%)
Tremor
4 (.96%)
Arthritis
3 (.72%)
Blood Bilirubin Increased
3 (.72%)
Blood Creatine Phosphokinase Increa...
3 (.72%)
Cardiac Arrest
3 (.72%)
Cardiac Failure Acute
3 (.72%)
Cholangitis
3 (.72%)
Colitis Ischaemic
3 (.72%)
Decreased Appetite
3 (.72%)
Depressed Level Of Consciousness
3 (.72%)
Dizziness
3 (.72%)
Dysgeusia
3 (.72%)
Enterocolitis Haemorrhagic
3 (.72%)
Gastroenteritis
3 (.72%)
Gastrointestinal Inflammation
3 (.72%)
Granulocytopenia
3 (.72%)
Haematochezia
3 (.72%)
Hypoaesthesia Facial
3 (.72%)
Mallory-weiss Syndrome
3 (.72%)
Palpitations
3 (.72%)
Peripheral Coldness
3 (.72%)
Abdominal Pain Upper
2 (.48%)
Anti-neutrophil Cytoplasmic Antibod...
2 (.48%)
Asphyxia
2 (.48%)
Blood Pressure Decreased
2 (.48%)
Body Temperature Decreased
2 (.48%)
Death
2 (.48%)
Dehydration
2 (.48%)
Diarrhoea Haemorrhagic
2 (.48%)
Drug Ineffective
2 (.48%)
Drug Interaction
2 (.48%)
Dysarthria
2 (.48%)
Face Oedema
2 (.48%)
Flank Pain
2 (.48%)
Gastric Ulcer Haemorrhage
2 (.48%)
Gastroenteritis Eosinophilic
2 (.48%)
Inappropriate Antidiuretic Hormone ...
2 (.48%)
International Normalised Ratio Incr...
2 (.48%)
Jaundice
2 (.48%)
Liver Disorder
2 (.48%)
Melaena
2 (.48%)
Mouth Ulceration
2 (.48%)
Musculoskeletal Stiffness
2 (.48%)
Oculomucocutaneous Syndrome
2 (.48%)
Paraesthesia
2 (.48%)
Pseudodementia
2 (.48%)
Rash
2 (.48%)
Syncope
2 (.48%)
Therapeutic Agent Toxicity
2 (.48%)
Urinary Tract Infection
2 (.48%)
Vaginal Haemorrhage
2 (.48%)
White Blood Cell Count Decreased
2 (.48%)
Abdominal Discomfort
1 (.24%)
Abnormal Behaviour
1 (.24%)
Adverse Drug Reaction
1 (.24%)
Aphthous Stomatitis
1 (.24%)
Blood Alkaline Phosphatase Increase...
1 (.24%)
Blood Glucose Increased
1 (.24%)
Bronchopneumonia
1 (.24%)
C-reactive Protein Increased
1 (.24%)
Cardioactive Drug Level Increased
1 (.24%)
Cerebrovascular Accident
1 (.24%)
Cheilitis
1 (.24%)
Cold Sweat
1 (.24%)
Contusion
1 (.24%)
Daydreaming
1 (.24%)
Diabetes Mellitus Inadequate Contro...
1 (.24%)
Disorientation
1 (.24%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Zithromac Sr, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zithromac Sr is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zithromac Sr

What are the most common Zithromac Sr adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zithromac Sr, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zithromac Sr is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Zithromac Sr According to Those Reporting Adverse Events

Why are people taking Zithromac Sr, according to those reporting adverse events to the FDA?

Pneumonia
23
Bronchitis
19
Nasopharyngitis
14
Pharyngitis
12
Upper Respiratory Tract Inflammatio...
12
Pyrexia
6
Show More Show More
Infection Prophylaxis
6
Infection
5
Respiratory Tract Infection
5
Periodontitis
4
Urinary Tract Infection
4
Oropharyngeal Pain
3
Acute Tonsillitis
3
Pneumonia Mycoplasmal
2
Bronchiolitis
2
Chlamydial Infection
2
Acne
2
Acute Sinusitis
2
Cough
2
Gonorrhoea
2
Pharyngitis Bacterial
2
Tracheobronchitis Mycoplasmal
1
Prophylaxis
1
Stomatitis
1
Skin Infection
1
Upper Respiratory Tract Infection
1
Urethritis
1
Gingival Swelling
1
Antibiotic Prophylaxis
1
Pericoronitis
1
Osteitis
1
Asthma
1
Chronic Sinusitis
1
Chronic Obstructive Pulmonary Disea...
1
Urethritis Chlamydial
1
Otitis Media
1
Pyelonephritis
1
Arteriosclerosis
1

Zithromac Sr Case Reports

What Zithromac Sr safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Zithromac Sr. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Zithromac Sr.